Mean cost of hospitalizations with chromosomal birth defect U.S.| ��ƽ��

Mean cost of U.S. hospitalizations with a chromosomal birth defect–associated discharge diagnosis in 2019 (in U.S. dollars)

Characteristic	Mean cost in U.S. dollars
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Release date

July 2023

More information

Region

United States

Survey time period

2019

Age group

Younger than 65 years

Supplementary notes

The source notes that hospitalizations with at least one birth defect–associated discharge diagnosis were identified "by scanning up to 40 available fields for ICD-10-CM diagnosis codes Q00–Q99: congenital malformations, deformations, and chromosomal abnormalities. Patent ductus arteriosus (Q25.0) and atrial septal defect (Q21.1) were not considered birth defects when occurring in neonates aged <28 days or with an associated indicator of preterm birth (ICD-10-CM codes P07.2 or P07.3). An additional 23 conditions of lesser clinical importance classified within the Q00–Q99 code range were not considered birth defects."

Concerning birth defect categories the source notes: " Birth defects categories correspond to blocks of ICD-10-CM diagnosis codes: cardiovascular (Q20–Q28), central nervous system (Q00–Q07), chromosomal (Q90–Q99), cleft lip/palate (Q35–Q37), ear (Q16–Q17), eye (Q10–Q15), gastrointestinal (Q38–Q45), genitourinary (Q50–Q64), integumentary (Q80–Q85), musculoskeletal (Q65– Q79), and other syndrome (Q87). “Other defect” includes birth defects of the face and neck (Q18), respiratory system (Q30–Q34), and other congenital malformations (Q86 and Q89)."

Citation formats

In 2019, it was estimated that the mean cost of hospitalizations with a trisomy 21, also known as Down syndrome, discharge diagnosis among those aged less than 65 years was around * U.S. dollars. Down syndrome is a genetic condition that can affect how the brain and body develop and is the most common chromosomal condition in the United States. This statistic shows the mean cost of U.S. hospitalizations with a chromosomal birth defect–associated discharge diagnosis among those aged less than 65 years in 2019.